In a murine study, L-glutamine supplementation improved DSS-induced colitis, decreased macroscopic damage, decreased TNF-α production in parallel, improved the disease activity index, and induced MKP-1, which inhibited cytosolic phospholipase A2 (cPLA2) [171]. This evidence concerns the gene PLA2G4A and colitis.